Wonke umuntu uyazi ukuthi izinga eliphezulu le-cholesterol liyinhloko enkulu engozini ye- coronary artery disease (CAD) . Uma unengozi enkulu yokuthuthukisa i-CAD, noma ikakhulukazi uma usuvele unayo i-CAD, ungaqiniseka ukuthi udokotela wakho uzokukhuthaza ukuba unciphise amazinga wakho we-cholesterol, futhi mhlawumbe angabeka umuthi we- statin ukukusiza ukuba wenze kanjalo.
Ngakho-ke kungahle kusimangaze ukuthi kubantu abangaphezu kweminyaka engama-65 - iqembu lobudala elinesici esiphezulu se-CAD - ukuthi benzeni ngamanqanaba ephezulu we-cholesterol kuye kwaba nokuphikisana okuthile.
Kungani Ukuphikisana?
Ukungqubuzana kukhona ngoba abantu asebekhulile baye baxoshwa ngendlela ehlelekile ezinhlolweni eziningi zokwelashwa ezibonisa izinzuzo zokwelashwa kwe-cholesterol. Kuyadabukisa ukuthi ukuvivinywa kwezidakamizwa kuzo zonke izinhlobo ngokuvamile kuye kugweme ukubhalisa iziguli asebekhulile.
Lokhu akusho ukuthi izinkampani zezidakamizwa zibheke abantu abadala ukuba bangafaneleki ukunakwa kwabo, kodwa kunalokho ngezizathu ezingokoqobo nezomnotho. Abantu asebekhulile banomkhawulo wokuphila okunciphise, ngakho-ke abanye babo bangase bafe ngesikhathi sokuvivinywa komtholampilo eside ngenxa yezizathu ezingahambisani nhlobo nokwelashwa okuhlolwe. Futhi, abantu asebekhulile bavame ukuba nezimo ezingaphezu kweyodwa zezokwelapha, ngakho-ke bavame ukuba nezibonakaliso eziningi - ezinye zazo okungenzeka ukuthi zenziwe ngokungalungile kumuthi wokuhlola. Ukufa kanye nezimpawu ezinjalo "ezingaphandle" kungenza kube nzima kakhulu ukuhlaziywa kwesilingo somtholampilo futhi kungasongela ukugunyazwa kwe-FDA ekugcineni kwesidakamizwa esisha.
Ngakho kuye kwaba okuphephile (futhi kuyabiza) ukushiya abantu abadala kuphela ezinhlolweni eziningi zokwelashwa.
Lo mkhuba wokubambelela usho ukuthi siyazi kancane ngezinzuzo ezithile kanye nezingozi zokuphatha amazinga aphezulu e-cholesterol kubantu asebekhulile. Futhi lokhu, kusho ukuthi uma isiguli esidala sinamazinga aphezulu e-cholesterol, odokotela bavame ukuqiniseka ukuthi kufanele banikeze ukwelashwa.
I-Cholesterol Nezifo Zenhliziyo Ebekhulile
Kubantu bobulili bobabili abaneminyaka engaphezu kwengu-65 ubudala, isifo senhliziyo sifunda ngaphezu kwengxenye yazo zonke ukufa. Uma kuqhathaniswa, umdlavuza ukhiqiza "u-24% kuphela wokufa kwabantu" kule nkathi yobudala kanye no-20% kwabesifazane. Ngakho ukwelashwa okunganciphisa ingozi yesifo senhliziyo kubantu asebekhulile kufanele kube into efiselekayo.
Ngaphezu kwalokho, i-cholesterol ephakeme ihlotshaniswa nenengozi yokwanda yesifo senhliziyo kubantu abadala njengoba nje kunabantu abasha. Eqinisweni, okungenani ubufakazi obunye bubonisa ukuthi i-cholesterol ingaba yinto ebaluleke nakakhulu ebungozini asebekhulile kunabantu abasha.
Ingabe Kuyasiza Ukunciphisa Izinga Le-Cholesterol Kubantu Abadala?
Naphezu kokungabikho kobufakazi obuvela ezivivinyweni zomtholampilo kubantu asebekhulile, ukuphazamiseka kobufakazi okwamanje kubonisa ukuthi ukwelashwa kwe-cholesterol ephakeme kwasebekhulile kuyinto okungenani okufanele icatshangwe ngokujulile.
Idatha ephelele itholakala ezinhlolweni eziningana zokwelashwa okungahleliwe kwi-cholesterol therapy ukuze kuvunyelwe ukuhlaziywa kwamacembu kubantu asebekhulile. Izifundo zokuhlanganisa idatha kwezinye zezilingo ziye zaphetha ngokuthi imiphumela yomzimba ingathuthukiswa ngokuphatha amazinga ephakeme we-cholesterol nemithi yesimiso kubantu asebekhulile okungenani kubantu abancane.
Ngaphezu kwalokho, ukunciphisa ingozi yempilo kubantu abadala kuvame ukubonakala ezinyangeni ezimbalwa zokuqala ukwelapha, ngakho-ke naphezu kokuthi lezi ziguli zidala, "azikho" kakhulu ukuze zithole izinzuzo ze-cholesterol ezinciphisa izitho zomzimba.
Ngakho-ke, kuyilapho izinzuzo ezikhona zokuncipha kwe-cholesterol zingabonakali ngokucacile kubantu asebekhulile kunabantu abasebasha, ubufakazi obukhona obukhona bukhona bukhona bukhona bokuthi kunenzuzo enkulu yokwelapha i-cholesterol kubantu asebekhulile.
Imiphumela emibi yamaSitatimende kubantu asebekhulile
Ubufakazi obutholakalayo bubonisa ukuthi ingozi yemiphumela emibi evela ezihlotsheni ayikho emalini asebekhulile kuneziguli ezincane.
Kodwa-ke, bobabili odokotela neziguli kudingeka baqaphele ukuthi ezinye zezinto ezingase zibe nemiphumela emibi yesimiso (ezifana nezinkinga zemisipha nokuphazamiseka kwengqondo ) zingase zibe nemiphumela engcono kakhulu kulabo asebekhulile kuneziguli ezincane.
Okubalulekile
Uma ungumuntu omdala onengozi ye-cardiac ephakeme - noma ikakhulukazi uma usuvele unayo i-CAD - kanti naphezu kokuntuleka kobufakazi obucacile bokuphatha i-cholesterol yakho kuzuzisa, kunobunye ubufakazi obanele ukuba kube nomqondo omuhle ukuba okungenani ube ne- ukuxoxisana nodokotela wakho nge-cholesterol therapy.
Kubantu asebekhulile abanenkinga eminingi yezokwelapha, izingozi ezingenzeka zokufaka esinye isinye imishanguzo ohlelweni oluyinkimbinkimbi yezidakamizwa lungase luveze kakhulu izinzuzo ezikhona. Kodwa kubantu abadala asebekhulile abanamazinga aphezulu e-cholesterol, ukwelashwa kwehlisa i-cholesterol kufanele kucatshangelwe ngokujulile.
Imithombo:
Neil HA, DeMicco DA, uLoo D, et al. Ukuhlaziywa kokusebenza nokuphepha kweziguli ezineminyaka engama-65-75 ngokungahleliwe: Isifundo Sokubambisana Sase-Atorvastatin Sikashukela (IKHADI). Ukunakekelwa yisifo sikashukela 2006; 29: 2378.
U-Allen Maycock CA, uMuhlestein JB, uHorne BD, et al. Ukwelashwa kwe-statin kuhlotshaniswa nokufa okunciphise kuzo zonke izigaba zabantu ngabanye abanezifo ezibalulekile ze-coronary, kuhlanganise neziguli ezigugile kakhulu. J Am Coll Cardiol 2002; 40: 1777.
UWenger NK, Lewis SJ, uHerrington DM, et al. Imiphumela yokusebenzisa i-atorvastatin ephezulu noma ephansi etigulini ezineminyaka engu-65 ubudala noma ngaphezulu nge-coronary heart disease. U-Ann Intern Med 2007; 147: 1.
Sacks FM, Tonkin AM, Umalusi J, et al. Umphumela we-pravastatin kwi-coronary disease izenzakalo ezinkampanini ezichazwe yizici ezinobungozi be-coronary: Project Prospective Pravastatin Pooling Project. Ukujikeleza kuka-2000; 102: 1893.
Savarese G, Gotto AM Jr, Paolillo S, et al. Izinzuzo zezimo ezisebekhulile ngaphandle kwezifo zesifo senhliziyo: ukuhlaziywa kwe-meta. J Am Coll Cardiol 2013; 62: 2090.